• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS21
Device Problems Perivalvular Leak (1457); Incomplete Coaptation (2507); Malposition of Device (2616)
Patient Problems Aortic Insufficiency (1715); Death (1802)
Event Date 04/12/2017
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2017 a small perceval valve was implanted through a right anterior thoracotomy.Upon deployment of the valve, it was noticed that the leaflets were not fully coapting.A 5 mm scope was used to determine that the valve was properly placed.The trans esophageal echo showed a large central leak, as well as a moderate pvl on the non coronary cusp.The surgeon then performed a full sternotomy to assess the valve placement.The valve was found to be seated too high on the non coronary cusp.It did appear to be properly collapsed onto the holder at the time of implantation.The valve was then removed, and annulus was resized to confirm that the proper size was implanted.The surgeon decided not to re-implant the valve lower on the non coronary side, because he felt that this would not fix the large central leak that was present.A sutured crown prt size 21 valve was then placed.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was reported that per the patient's obituary, the patient passed away peacefully on (b)(6) 2017 following complications of surgery.
 
Manufacturer Narrative
The visual inspection performed on the returned prosthesis confirmed the absence of manufacturing defects.The hydrodynamic testing conducted on the returned prosthesis confirmed that the device was showing a normal leaflet kinematics with a regurgitation fraction in compliance with requirement of en iso5840:2015.Based on the performed analysis, the reported event cannot be explained by any factor intrinsic in the involved device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 fraser north way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 fraser north way
burnaby, bc 
MDR Report Key6563202
MDR Text Key75031049
Report Number3004478276-2017-00083
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000412
UDI-Public(01)00896208000412(240)ICV1208(17)190719
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 07/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/12/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date07/19/2019
Device Model NumberPVS21
Device Catalogue NumberICV1208
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/04/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/27/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/19/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
-
-